Zaleplon Capsule
Product Images NDC 43063-783

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zaleplon (NDC 43063-783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

33862046 1ed3 4ae0 9cee 4fa42b6bb6e0 01

Chemical structure diagram of the active ingredient zaleplon, showing its molecular framework with labeled functional groups and rings as part of the drug's chemical composition.*

FDA Label Image

Image (43063783)

Label for zaleplon USP 10 mg oral capsules, packaged as 10 capsules per container. The product is labeled by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK. The label includes NDC 43063-783-10, lot number A20A42, and expiration date 01/2022. The label also displays warnings, reorder information, and barcode markings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.